techSeptember 15, 2026·MIT Tech Review
AI models need more data about biology, and OpenAI is paying to create it
Last year Ruxandra Teslo, a policy analyst who focuses on clinical trials, posted an idea for supercharging medical AI systems: Use data from failed biotech companies. By bidding at their bankruptcy proceedings, she proposed, it might be possible to obtain detailed regulatory filings, manufacturing
Last year Ruxandra Teslo, a policy analyst who focuses on clinical trials, posted an idea for supercharging medical AI systems: Use data from failed biotech companies. By bidding at their bankruptcy proceedings, she proposed, it might be possible to obtain detailed regulatory filings, manufacturing strategies, and safety data—types of information usually considered trade secrets. She…
Key Takeaways
- •Last year Ruxandra Teslo, a policy analyst who focuses on clinical trials, posted an idea for supercharging medical AI systems: Use data from failed biotech companies
- •This story was reported by MIT Tech Review, covering developments in the tech space.
- •AI advancements continue to reshape industries — read the full article on MIT Tech Review for complete coverage.
📖 Continue reading the full article:
Read Full Article on MIT Tech Review →
